ChemComm
Communication
that CP 1 could distinguish Fe3+ from Fe2+. The competition experiment (Fig. 3g) were observed. Moreover, the treatment of Hela cells with
showed that the response of the probe CP 1 toward Fe3+ is unaffected probe CP 1 or Fe(NO3)3 did not result in any critical change in the cell
by the presence of the other possible contaminating metal ions (the morphology or cell death (Fig. 3a and e), indicating that the cellular
gray bar portion in Fig. 2), demonstrating that our new designed probe toxicity of probe CP 1 is negligible. These preliminary experimental
CP 1 could meet the selective requirements for biomedical and results demonstrate that probe CP 1 could be applied to ratiometric
environmental applications. The high selectivity of probe CP 1 might imaging of Fe3+ in biological samples at high resolution.
be ascribed to the high specificity of the Fe3+-induced ring-opening
In summary, we have designed and synthesized a rhodamine-
reaction of the spirolactam structure of CP 1 through the chelation of appended water-soluble conjugated polymer CP 1 as a FRET-based
Fe3+ with the two oxygen atoms and two nitrogen atoms of the ratiometric probe for intracellular Fe3+ probing. With no requirement
rhodamine 6G moiety (Scheme 1), which triggered the FRET of CP 1 of any organic cosolvent, CP 1 exhibits excellent solubility in pure
to afford ratiometric fluorescence response toward Fe3+.10c,13b–f
aqueous solutions. It shows two well-resolved emission peaks, which
The chemical reversibility behavior of the binding of CP 1 with benefits observation of double-channel fluorescence signal changes at
Fe3+ was then studied in the buffered aqueous solution (see Fig. S4, high resolution. In addition, probe CP 1 shows high selectivity and
ESI†), which indicated that the Fe3+ binding of CP 1 in buffered good reversibility toward Fe3+. The excellent water-solubility, the high
solution is chemically reversible. The response time of the probe sensitivity and selectivity, and the good reversibility of the CP probe
toward Fe3+ is concentration-dependent, and the reaction of the may provide a new platform for intracellular metal-ion probing.
probe and 8 mM of Fe3+ was completed within 5 min (see Fig. S5,
This work was supported by the National Key Scientific Program
ESI†), which is favorable for real-time tracking of the Fe3+ levels in of China (2011CB911000), NSFC (Grants 21325520, 21327009,
biological samples. The practical applications of the designed probe 21221003, J1210040, 21177036, 21135001), the National Instrumen-
were further evaluated by the detection of the recovery of spiked Fe3+ tation Program (2011YQ030124), the Ministry of Education of China
in river water (see Table S1, ESI†). The results obtained in real water (20100161110011), and the Hunan Provincial Natural Science
samples show good recovery values, which confirmed that the Foundation (Grant 11JJ1002).
proposed probe was applicable for practical Fe3+ detection in real
samples with other co-existing potentially competing species.
Notes and references
1 (a) L. A. Finney and T. V. O’Halloran, Science, 2003, 300, 931;
The excellent water-solubility, the high sensitivity and the good
reversibility, together with the two well-resolved emission peaks of
CP 1, should benefit ratiometric imaging of Fe3+ in biological
samples at high resolution. Consequently, we performed the ratio-
metric confocal fluorescence imaging experiment for Fe3+ in living
cells. Fig. 3 shows the results of double-channel fluorescence
imaging of intracellular Fe3+ ions with CP 1 at 440 Æ 10 and
540 Æ 10 nm. Hela cells incubated with CP 1 for 1 hour showed a
strong blue intracellular fluorescence (Fig. 3b) and a very weak
orange intracellular fluorescence (Fig. 3c), which indicated that CP
1 could penetrate cells. When cells pre-treated with CP 1 were
further incubated with exogenous Fe(NO3)3 in PBS for 1 hour and
washed, a nearly complete disappearance of the blue fluorescence
(Fig. 3f) and a notable enhancement of the orange fluorescence
(b) A. B. G. Lansdown, Crit. Rev. Toxicol., 1995, 25, 397.
2 (a) Y. M. Yang and F. Y. Li, Chem. Rev., 2013, 113, 192; (b) D. T. Quang
and J. S. Kim, Chem. Rev., 2010, 110, 6280; (c) E. M. Nolan and
S. J. Lippard, Chem. Rev., 2008, 108, 3443.
3 L. J. Fan, M. M. Hu, P. Zhan and X. J. Peng, Chem. Soc. Rev., 2013, 42, 29.
4 (a) T. M. Swager, Acc. Chem. Res., 1998, 31, 201; (b) D. T. McQuade
and T. M. Swager, Chem. Rev., 2000, 100, 2537; (c) S. W. Thomas and
T. M. Swager, Chem. Rev., 2007, 107, 1339; (d) X. Feng, S. Wang and
D. Zhu, Chem. Soc. Rev., 2010, 39, 2411; (e) L. Chen and
D. G. Whitten, Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 12287.
5 (a) M. Stork and G. C. Bazan, Adv. Mater., 2002, 14, 361; (b) S. Wang,
B. Liu, B. S. Gaylord and G. C. Bazan, Adv. Funct. Mater., 2003,
13, 463; (c) C. Tan and K. S. Schanze, Adv. Mater., 2004, 16, 1208.
6 (a) B. Liu and G. C. Bazan, Chem. Mater., 2004, 16, 4467; (b) M. R. Pinto
and K. S. Schanze, Synthesis, 2002, 1293; (c) J. J. Lavigne and U. H. F. Bunz,
Macromolecules, 2003, 36, 7409; (d) C. Y. Tan and K. S. Schanze, J. Am.
Chem. Soc., 2004, 126, 13685.
7 V. Dujols, F. Ford and A. W. Czarnik, J. Am. Chem. Soc., 1997, 119, 7386.
8 Y. K. Yang, K. J. Yook and J. Tae, J. Am. Chem. Soc., 2005, 127, 16760.
9 X. Q. Chen and J. Yoon, Chem. Rev., 2012, 112, 1910.
10 (a) X. L. Zhang, Y. Xiao and X. H. Qian, Angew. Chem., Int. Ed., 2008,
47, 8025; (b) M. H. Lee and J. S. Kim, Org. Lett., 2008, 10, 213;
(c) Z. G. Zhou, F. Y. Li and C. H. Huang, Chem. Commun., 2008, 3387;
(d) X. Cao, W. Lin and Y. Ding, Chem.–Eur. J., 2011, 17, 9066;
(e) C. Y. Li, Y. Zhou, Y. F. Li, C. X. Zou and X. F. Kong, Sens.
Actuators, B, 2013, 186, 360.
11 J. B. Neilands, Biol. Met., 1991, 4, 1.
12 (a) D. Galaris, V. Skiada and A. Barbouti, Cancer Lett., 2008, 266, 21;
(b) S. Swaminathan and V. S. Shah, Diabetes Care, 2007, 30, 1926.
13 (a) J. L. Bricks, J. Daub and K. Rurack, J. Am. Chem. Soc., 2005,
127, 13522; (b) Y. Xiang and A. Tong, Org. Lett., 2006, 8, 1549;
(c) J. Mao and W. Liu, Org. Lett., 2007, 9, 4567; (d) Z. Q. Hu, Chem.
Commun., 2011, 47, 1622; (e) J. D. Chartres, J. J. Davis and
P. V. Bernhardt, Inorg. Chem., 2011, 50, 9178; ( f ) Y. Wei and
M. Guo, ChemBioChem, 2012, 13, 1569.
14 Y. Zhang, C. B. Murphy and W. E. Jones, Macromolecules, 2002, 35, 630.
15 (a) H. Lu, U. Woggon and C. M. Niemeyer, J. Am. Chem. Soc., 2008,
130, 4815; (b) H. Zhang, Y. Guo and D. Zhou, Nanoscale, 2013,
5, 10307.
Fig. 3 Images of Hela cells treated with probe CP 1 in the absence or
presence of Fe3+. (a) Bright field image of Hela cells incubated with CP 1
([RU] = 10 mM) for 1 h; (b) fluorescence image of (a) from channel 1;
(c) fluorescence image of (a) from channel 2; (d) merge image of frames
(a), (b), and (c); (e) bright field image of Hela cells incubated with CP 1
([RU] = 10 mM) for 1 h, then treated with Fe3+ (5 Â 10À4 M) for another 1 h;
(f) fluorescence image of (e) from channel 1; (g) fluorescence image of
(e) from channel 2; (h) merge image of frames (e), (f), and (g). Excitation
was set at 405 nm.
16 L. J. Fan, Y. Zhang and W. E. Jones, J. Am. Chem. Soc., 2006,
128, 6784.
2042 | Chem. Commun., 2014, 50, 2040--2042
This journal is ©The Royal Society of Chemistry 2014